1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Non-invasive Brain Stimulation System Market Forecast
4.4. Global Non-invasive Brain Stimulation System Market Outlook
5. Market Outlook
5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.2. Key product/Brand Analysis
5.3. Diseases Epidemiology
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Product Type
6.1. Introduction
6.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
6.3. Global Non-invasive Brain Stimulation System Market Forecast, by Product Type
6.3.1. Transcranial Magnetic Stimulation (TMS) System
6.3.2. Transcranial Current Stimulation (TCS) System
6.4. Global Non-invasive Brain Stimulation System Market Analysis, by Product Type
7. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by Application
7.1. Introduction
7.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
7.3. Global Non-invasive Brain Stimulation System Market Forecast, by Application
7.3.1. Depression
7.3.2. Epilepsy
7.3.3. Parkinson’s Disease
7.3.4. Chronic Pain
7.3.5. Others
7.4. Global Non-invasive Brain Stimulation System Market Analysis, by Application
8. Global Non-invasive Brain Stimulation System Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
8.3. Global Non-invasive Brain Stimulation System Market Forecast, by End-user
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Specialty Clinics
8.3.4. Others
8.4. Global Non-invasive Brain Stimulation System Market Analysis, by End-user
9. Global Non-invasive Brain Stimulation System Market Analysis, by Region
9.1. Global Non-invasive Brain Stimulation System Market Analysis, by Region
9.2. Global Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Region
9.3. Global Non-invasive Brain Stimulation System Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Non-invasive Brain Stimulation System Market Analysis
10.1. North America Non-invasive Brain Stimulation System Market Overview
10.2. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
10.3. North America Non-invasive Brain Stimulation System Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
10.5. North America Non-invasive Brain Stimulation System Market Forecast, by Product Type
10.5.1. Transcranial Magnetic Stimulation (TMS) System
10.5.2. Transcranial Current Stimulation (TCS) System
10.6. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
10.7. North America Non-invasive Brain Stimulation System Market Forecast, by Application
10.7.1. Depression
10.7.2. Epilepsy
10.7.3. Parkinson’s Disease
10.7.4. Chronic Pain
10.7.5. Others
10.8. North America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
10.9. North America Non-invasive Brain Stimulation System Market Forecast, by End-user
10.9.1. Hospitals
10.9.2. Ambulatory Surgical Centers
10.9.3. Specialty Clinics
10.9.4. Others
11. Europe Non-invasive Brain Stimulation System Market Analysis
11.1. Europe Non-invasive Brain Stimulation System Market Overview
11.2. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Europe Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
11.3.1. Germany
11.3.2. U.K.
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
11.5. Europe Non-invasive Brain Stimulation System Market Forecast, by Product Type
11.5.1. Transcranial Magnetic Stimulation (TMS) System
11.5.2. Transcranial Current Stimulation (TCS) System
11.6. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
11.7. Europe Non-invasive Brain Stimulation System Market Forecast, by Application
11.7.1. Depression
11.7.2. Epilepsy
11.7.3. Parkinson’s Disease
11.7.4. Chronic Pain
11.7.5. Others
11.8. Europe Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
11.9. Europe Non-invasive Brain Stimulation System Market Forecast, by End-user
11.9.1. Hospitals
11.9.2. Ambulatory Surgical Centers
11.9.3. Specialty Clinics
11.9.4. Others
12. Asia Pacific Non-invasive Brain Stimulation System Market Analysis
12.1. Asia Pacific Non-invasive Brain Stimulation System Market Overview
12.2. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
12.3.1. China
12.3.2. India
12.3.3. Japan
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
12.5. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Product Type
12.5.1. Transcranial Magnetic Stimulation (TMS) System
12.5.2. Transcranial Current Stimulation (TCS) System
12.6. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
12.7. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by Application
12.7.1. Depression
12.7.2. Epilepsy
12.7.3. Parkinson’s Disease
12.7.4. Chronic Pain
12.7.5. Others
12.8. Asia Pacific Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
12.9. Asia Pacific Non-invasive Brain Stimulation System Market Forecast, by End-user
12.9.1. Hospitals
12.9.2. Ambulatory Surgical Centers
12.9.3. Specialty Clinics
12.9.4. Others
13. Latin America Non-invasive Brain Stimulation System Market Analysis
13.1. Latin America Non-invasive Brain Stimulation System Market Overview
13.2. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
13.5. Latin America Non-invasive Brain Stimulation System Market Forecast, by Product Type
13.5.1. Transcranial Magnetic Stimulation (TMS) System
13.5.2. Transcranial Current Stimulation (TCS) System
13.6. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
13.7. Latin America Non-invasive Brain Stimulation System Market Forecast, by Application
13.7.1. Depression
13.7.2. Epilepsy
13.7.3. Parkinson’s Disease
13.7.4. Chronic Pain
13.7.5. Others
13.8. Latin America Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
13.9. Latin America Non-invasive Brain Stimulation System Market Forecast, by End-user
13.9.1. Hospitals
13.9.2. Ambulatory Surgical Centers
13.9.3. Specialty Clinics
13.9.4. Others
14. Middle East & Africa Non-invasive Brain Stimulation System Market Analysis
14.1. Middle East & Africa Non-invasive Brain Stimulation System Market Overview
14.2. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Country
14.3. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Country/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of Middle East & Africa
14.4. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Product Type
14.5. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Product Type
14.5.1. Transcranial Magnetic Stimulation (TMS) System
14.5.2. Transcranial Current Stimulation (TCS) System
14.6. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by Application
14.7. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by Application
14.7.1. Depression
14.7.2. Epilepsy
14.7.3. Parkinson’s Disease
14.7.4. Chronic Pain
14.7.5. Others
14.8. Middle East & Africa Non-invasive Brain Stimulation System Market Value Share and Attractiveness Analysis, by End-user
14.9. Middle East & Africa Non-invasive Brain Stimulation System Market Forecast, by End-user
14.9.1. Hospitals
14.9.2. Ambulatory Surgical Centers
14.9.3. Specialty Clinics
14.9.4. Others
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Brainbox Ltd.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. BrainsWay
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. eNeura, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4. Flow Neuroscience
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Strategic Overview
15.2.4.4. SWOT Analysis
15.2.5. Magnus Medical, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Magstim
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Strategic Overview
15.2.6.4. SWOT Analysis
15.2.7. MagVenture
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. NeoSync, Inc. (Wave Neuroscience, Inc.)
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Strategic Overview
15.2.8.4. SWOT Analysis
15.2.9. NeuraLace
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Strategic Overview
15.2.9.4. SWOT Analysis
15.2.10. neurocare group AG
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Strategic Overview
15.2.10.4. SWOT Analysis
15.2.11. NeuroMetrix
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. Strategic Overview
15.2.11.4. SWOT Analysis
15.2.12. Neuronetics
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Product Portfolio
15.2.12.3. Strategic Overview
15.2.12.4. SWOT Analysis
15.2.13. Soterix Medical, Inc.
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Product Portfolio
15.2.13.3. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/